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Abstract. Alamethicin and related α-aminoisobutyric acid peptides form transmembrane
channels across lipid bilayers. This article briefly reviews studies on the effect of alamethicin 
on lipid phase transitions in lipid bilayers and on mitochondrial oxidative phosphorylation. 
Fluorescence polarization studies, employing 1,6-diphenyl-1,3,5-hexatriene as a probe, suggest
that alamethicin fluidizes lipid bilayers below the phase transition t-emperature, but has little
effect above the gel-liquid crystal transition point. Alamethicin is shown to function as an 
uncoupler of oxidative phosphorylation in rat liver mitochondria. The influence of alamethicin 
on mitochondrial respiration is modulated by the phosphate ion concentration in the medium. 
Classical uncoupling activity is evident at low phosphate levels while inhibitory effects set in at 
higher phosphate concentrations. Time-dependent changes in respiration rates following 
peptide addition are rationalized in terms of alamethicin interactions with mitochondrial 
membrane components. 
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Introduction 
 
Alamethicin and related α-aminoisobutyric acid (Aib) containing peptides of microbial 
origin, form voltage dependent channels across lipid bilayer membranes (Mathew and 
Balaram, 1983a, 1984; Jung et al., 1981; Mueller and Rudin, 1968; Mueller, 1976; Hall, 
1978). These systems provide an excellent model for investigating the molecular events 
involved in the formation and gating of membrane channels. Over the past few years 
considerable effort has been devoted towards establishing the structural characteristics 
of these channel forming peptides (Nagaraj and Balaram, 1981; Prasad and Balaram, 
1984; Toniolo et al., 1983; Smith et al., 1981; Fox and Richards, 1982; Banerjee et al., 
1983; Schmitt et al., 1982). Figure 1 lists a few representative sequences for this class of 
peptides. The general consensus of these studies has favoured an overall helical 
conformation for these polypeptides, with channels being formed by aggregation of 
peptides in the lipid bilayer, generating supramolecular structures having a central 
aqueous core (figure 2) (Iqbal and Balaram, 1981; Fox and Richards, 1982).
An important feature of 310 or α-helical peptide structures is the existence of a 
macrodipole moment along the helix axis, with the amino and carboxy terminii serving 
 
 
Abbreviations used: Aib, α-Aminoisobutyric; DPH, 1,6-diphenyl-1,3,5-hexatriene; P, polarization; DPPC, 
dipalmitoylphosphatidyl choline; DMPC, dimayristoylphosphatidyl choline; Ρi, phosphate ions; FCCP, 
carbonylcyanide p-trifluoromethoxyphenylhydrazone 
. 
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Figure 1. Representative sequences of Aib containing membrane channel forming poly- 
peptides. All the naturally occurring peptides in this class are mixtures of very closely related 
polypeptides. A more complete listing of sequences may be found in Mathew and Balaram 
(1984). A discussion of separation and sequencing studies, with a critical analysis of 
heterogeneity of sequences is given by Bruckner and Przybylski (1984).
 
 
 
 
 
 
Figure 2. Schematic representation of transmembrane 
channel formation by lipid phase aggregation of helical, 
rodlike peptide structures.
 
 
 
 
 
as the positive and negative ends of the dipole, respectively (Wada, 1976; Hol et al., 
1981). In the case of alamethicin and the related peptide trichotoxin, dipole moments of 
40-75 D have been estimated experimentally in solvents like octanol and dioxane 
(Yantorno et al., 1982; Schwarz and Savko, 1982a,b; Schwarz et al., 1983).Dipole-dipole 
interactions may therefore play an important role in stabilizing aggregates of 
membrane spanning peptides in the lipid phase (Mathew and Balaram, 1983a,b, 1984). 
The conductivity characteristics of channels may then be modulated by changing 
aggregate size and also by altering transmembrane orientations of peptide monomers 
in the aggregate, thus changing the net dipole moment of the channel. Two recent 
models, which attempt to rationalise available experimental observations on potential 
dependent channel formation by alamethicin and data on pore state fluctuations, have 
ascribed a key role to helix dipole interactions (Mathew and Balaram, 1983b; Balaram, 
1983; Boheim et al., 1983; Jung et al., 1983). Figure 3 summarises the main features of a 
model for alamethicin channels proposed from this laboratory. It is clear that both 
peptide-peptide and peptide-lipid interactions will determine channel properties. For 
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Figure 3. Proposed model for voltage dependent channel formation by alamethicin.
(a) Aggregate of peptide helices in the aqueous phase. The projection represents a polar 
sidechain, presumably Gln (7). (b) Membrane phase aggregate formed by insertion of peptide 
aggregate into the bilayer and rotation about the helix axis of each molecule to form 
intermolecular hydrogen bonds. Α central peptide molecule (core piece) blocks the channel. 
(c) Voltage dependent extrusion of the core piece which would be a macrodipole. This is 
facilitated by lack of intermolecular hydrogen bonds to its neighbours. (d) Model for pore 
state transitions in which net dipole state or aggregation number changes. This occurs either by 
monomer exchange or peptide flip-flop across the bilayer (Mathew and Balaram, 1983b; 
Balaram, 1983). 
 
 
example, pore state lifetimes could be determined by membrane lipid ‘fluidity’; a more 
mobile lipid phase permitting facile peptide diffusion, leading to rapid formation and 
breakdown of functional aggregates. The effects of alamethicin and related amphi- 
pathic, helical peptides on natural membranes may be influenced by dipole-dipole 
interactions of the peptide with transmembrane segments of integral proteins.
Detailed accounts of the structural characteristics of alamethicin and its synthetic 
fragments (Nagaraj and Balaram, 1981; Prasad and Balaram, 1984; Jung et al., 1981; 
Fox and Richards 1982) and discussions of membrane modifying properties are 
available (Mathew and Balaram 1983a, 1984). There have been relatively few reports on 
the effects of alamethicin incorporation on the structural properties of artificial and 
natural membranes (Chapman et al., 1969; Hauser et al., 1970; Finer et al., 1969; Lau
and Chan, 1974, 1975, 1976; Mclntosh et al., 1982; Irmscher and Jung, 1977; Bessler et
al., 1979), in contrast to the large volume of electrochemical data on black lipid 
membrane systems. The observations that alamethicin pores result in the unmasking of 
inner surface membrane enzymes in diverse systems (Jones et al., 1977, 1980; Lad and 
White, 1979; Besch et al., 1977; Herman et al., 1980; Misselwitz et al., 1979; Bonnafous 
et al., 1982; Monneron and d’Alayer, 1980; Bessler et al., 1979), suggest that large 
channels can form in natural membranes. These, in turn, permit transmembrane 
passage of bulky, charged substrates. The observation that alamethicin (Takaishi et al., 
1980; Mathew et al., 1981a) and its synthetic fragments (Mathew et al., 1981a,b, 1982) 
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uncouple mitochondrial oxidative phosphorylation, has been interpreted in terms of 
effective dissipation of H+ gradients across the inner mitochondrial membrane by 
alamethicin channels (Mathew et al., 1981a, 1982). This article briefly reviews recent 
results from this laboratory on the effects of alamethicin on artificial lipid bilayers and 
oxidative phosphorylation in mitochondria. 
 
Peptide-lipid interactions 
 
Fluorescence polarization studies, using l,6-diphenyl-l,3,5-hexatriene (DPH) as a 
probe, can be employed to monitor the physical state of lipid bilayers. The gel-liquid 
crystal phase transition, is accompanied by a substantial increase in the disorder of the 
hydrocarbon chains of lipid molecules, resulting in increased rotational and trans- 
lational mobilities of dissolved spectroscopic probes. In the case of DPH incorporated 
into lipid bilayers, there is a large increase in rotational reorientation rates above the 
phase transition, leading to a significant fall in the value of the fluorescence polarization 
(P). DPH has therefore, been extensively employed as a probe of the microviscosity of 
artificial and natural membranes (Shinitzky and Barenholz, 1978).
Figure 4 shows the results of experiments designed to monitor the effects of peptide 
 
 
 
Figure 4.  Effect of peptides on the phase transition of DL-α-DPPC liposomes monitored using
DPH fluorescence polarization Ρ as a probe. (О), DPPC; (□) DPPC + suzukacillin fragment 
16G, (▲), DPPC + alamethicin fragment Z-1-17-OH, (∆), DPPC+alamethicin. Peptide: lipid mol
ratio is 1:2.3. DPPC (1·09 µmol) and peptide (0·46 µmol) were taken in CHCL3-CH3OH 
(2:1 v/v) and the solvent evaporated in a stream of nitrogen. The film was dried under vacuum, 
2 ml 5 mM HEPES-l00mM NaCl, pH 7.0 was added and the solution heated to 45°C and 
mixed vigorously on a vortex mixer. The suspension was sonicated until it became optically 
clear (Branson B-12 sonifier, output power 40 W). The solution was centrifuged to remove 
particulate matter. 1 ml of 2 µΜ DPH in the same buffer was added to 1 ml of the liposome 
solution. The solutions were incubated at 45°C for 2h to permit DPH incorporation. 
Polarization values were measured on a Perkin-Elmer MPF-44 Α fluorescence spectrometer 
equipped with a polarization accessory. λex = 360 nm, λem = 430 nm. Temperature control 
was accomplished using a thermostatted cell assembly and a controlled temperature water 
circulator. Polarization values are averages of 4 determinations.
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incorporation on the thermal phase transition of dipalmitoylphosphatidyl choline 
(DPPC) liposomes. In the absence of peptide DPPC shows a sharp transition centered 
at 41 °C, with Ρ values of 0·36–0·37 below the transition and values of ~ 0·08 above the 
transition temperature. Incorporation of 30 mole per cent of alamethicin, dramatically 
perturbs the bilayer, resulting in a large drop in the Ρ value even at 30°C. On heating the 
lipid-peptide complexes, a broad transition is observed, with very low Ρ values (~ 0·03) 
at higher temperatures. Alamethicin thus appears to "fluidize" the gel phase of DPPC 
liposomes. A 17-residue synthetic fragment of alamethicin (benzyloxycarbonyl-Aib- 
Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-OH, Ζ-1-17-
OH) and a 16-residue suzukacillin fragment (Boc-Ala-Aib-Ala-Aib-Aib-Gln-Aib-Leu- 
Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-OMe, 16G) were also examined. Figure 4 
demonstrates that both these peptides have a much less pronounced effect on DPPC 
bilayers, as compared to alamethicin. In both cases there is a detectable broadening of 
the phase transition. It is of interest to note that the limiting Ρ value at high temperature 
is significantly greater in the case of the neutral peptide 16 G, as compared to DPPC 
alone or in the presence of alamethicin or Z-1-17-OH. This may imply that 16 G forms 
a relatively more tightly packed peptide lipid complex above the lipid phase transition 
temperature. Both the 16 and 17 residue peptides have been shown to form channels 
which transport Ca2+ in synthetic liposomes (Nagaraj et al., 1980; Iqbal, 1982). Their 
activity is, however, less than that observed for alamethicin. Peptide aggregation in 
both aqueous and lipid phases may play an important role in channel formation 
(Mathew and Balaram, 1983a,b, 1984; Mathew et al., 1982). It has been shown that the 
ease of aqueous phase aggregation is dependent on peptide chain length, longer 
peptides associating at lower concentrations than shorter fragments (Mathew et al., 
1981b, 1982). The differential effects of the peptides on the lipid phase transition may 
reflect differences in their surface activity or 'detergent like' properties, with alamethicin 
acting as a more effective perturbant than its shorter fragments. It should be noted that 
peptide effects on the lipid phase transition have been monitored at significantly higher 
peptide-lipid ratios, than those employed in cation translocation studies (Nagaraj et al., 
1980; Mathew et al., 1982).
Figure 5 compares the effect of increasing alamethicin concentration on the Ρ values 
observed for DPH incorporated in DPPC, dimyristoylphosphatidyl choline (DMPC) 
 
 
 
 
 
 
 
 
Figure 5. Influence of alamethicin on the fluorescence polariz- 
ation of DPH incorporated into different liposomes, (∆), DPPC; 
(□) DMPC;(O), egg yolk lecithin. Lipid-peptide suspensions (28:1) 
were prepared as described in the legend to figure 4. Further 
increases of peptide concentration were accomplished by injection of 
1 µl of an alamethicin stock solution (9·8 mM) into the lipid 
suspensions, followed by sonicatio
described for figure 4. 
n. All other conditions are as 
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and egg lecithin vesicles. The phase transition temperatures for these systems, in the 
absence of peptide are 41°C, 23oC and –7 to – 15°C, respectively (Ladbrooke and 
Chapman, 1969). The experiments summarized in figure 5 were carried out at 25°C. 
Peptide incorporation lowers the Ρ value only in the case of DPPC, but is largely 
without effect on DMPC and egg lecithin, which are already in a fluid state above their 
respective transition temperatures. Peptide molecules appear to be easily incorporated 
into fluid bilayers, without further significant perturbation of lipid packing. This 
observation is of relevance for studies of peptide interaction with natural membrane 
systems, where lipid phases are generally in a ‘fluid’ state.
 
Peptide effects on mitochondria 
 
The energy derived from substrate oxidation in mitochondria is utilized for phos- 
phorylating ADP in mitochondria. The chemiosmotic hypothesis visualizes energy 
transduction via an electrochemical H+ and potential gradient across the inner 
mitochondrial membrane as a means of coupling the oxidation and phosphorylation 
reactions (Mitchell, 1966). Substances which break down transmembrane H+ or ion 
gradients (protonophores or ionophores) can serve to uncouple oxidative phosphory- 
lation (Green, 1977). Channel forming peptides would therefore be expected to act as 
uncouplers and indeed one pf the earliest characterized uncouplers was the peptide 
antibiotic, gramicidin A (Hotchkiss, 1944), The initial observation that the natural 
peptides alamethicin and hypelcin uncouple oxidative phosphorylation in rat liver 
mitochondria (Takaishi et al., 1980) was extended to demonstrate qualitatively similar
activities for synthetic alamethicin and its shorter fragments (Mathew et al., 1981a,b,
1982). Figure 6 shows representative experiments on the effect of various peptide 
 
 
 
Figure 6. Effect of alamethicin and its fragments on state 4 respiration of rat liver 
mitochondria. Substrate used was succinate. Numbers shown on traces indicate O2 
consumption in ng atoms O/min/mg mitochondrial protein. Peptide nomenclature: P-l-n-c 
where Ρ is the protecting group, n the number of residues in the alamethicin sequence and c the
C-terminal group. Ζ = benzyloxycarbonyl, Ac = acetyl, OMe = methyl ester, OBz = benzyl 
ester (Mathew and Balaram, 1984).
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fragments on oxygen consumption by mitochondria. Uncoupling efficiency depends on
chain length, with the longer peptides acting at lower concentrations. An interesting 
feature is that the uncoupling activity of alamethicin is dependent on the concentration 
of phosphate ions (Pi) in the medium. Significant enhancement of respiratory rates is 
observed at Pi concentrations between 1 and 10mM (Takaishi et al., 1980). While Pi 
dependent uncoupling has been observed in the case of the cationic cyanine dye 
uncouplers (Terada, 1979) and peptide carrier ionophores like valinomycin (Moore and 
Pressman, 1964), the role of Pi in this process remains to be clearly understood (Terada, 
1981). 
We have therefore examined the influence of a wide range of Pi concentrations 
(2·5–100 mM) on the effects of alamethicin on oxidative phosphorylation. Figure 7 
shows the effect of alamethicin on state 4 mitochondria at various peptide and Pi
concentrations. Upto 25 mM Pi alamethicin behaves as an uncoupler, stimulating 
respiration, at peptide concentrations varying from 0·045-0·3 µΜ. At a higher range of 
Pi concentrations (50–100 mM) there is an initial stimulation followed by a distinct 
reduction in the respiratory rate, suggestive of an inhibitory effect. This tendency is 
particularly evident in the results for alamethicin concentrations of 0·075-0·15 µΜ, at 
100 mM Pi. A further feature of interest is that at 2.5 mM Pi and low alamethicin 
concentration (0·075 µΜ), there is an initial lag period before stimulation of O2 
consumption sets in (figure 7a, trace i).
Figure 8 compares the effect of alamethicin, with those of the bee venom peptide 
melittin (H 2N - Gly - Ile - Gly - Ala - Val - Leu - Lys - Val - Leu - Thr - Thr - Gly - Leu - Pro - Ala - 
 
 
 
Figure 7. Effect of alamethicin on state 4 respiration in rat liver mitochondria suspended in 
media with Pi concentrations of (a) 2·5 mM, (b) 25 mM, (c) 50 mM and (d) 100 mM. 
Alamethicin concentrations are: (a) 0·075 µΜ (i), 0·105 µΜ (ii), 0·15 µΜ (iii), 0·30 µΜ (iv). 
(b) 0·045 µΜ (i), 0·075 µΜ (ii), 0·150 µΜ (iii), 0·30 µΜ (iv). (c) 0·03 µΜ (i), 0·045 µΜ (ii), 
0·075 µΜ (iii), 0·15 µΜ (iv), 0·3 µΜ (ν), (d) 0·0075 µΜ (i), 0·015 µΜ (ii), 0·03 µΜ (iii), 0·045 µΜ 
(iv), 0·075 µΜ (ν), 0·15 µΜ (vi). Mitochondrial protein concentration ~ 0·48 mg/ml. 
Mitochondria were isolated from rat liver by the procedure of Pedersen et al. (1978) and 
suspended in 2 ml of assay medium, containing D(–) mannitol (220 mM), sucrose (70 mM), 
HEPES (2 mM), EGTA (0·5 mM), MgCl2 (2·5 mM) and KH2 PO4 at varying concentrations as 
indicated. pH was adjusted to 7·0. Oxygen consumption was monitored using a Hansatech 
oxygen electrode at 33°C. Points 1,2,3 indicate additions of succinate (7·5 mM), ADP and 
alamethicin, respectively. ADP was added at concentrations of (a) 72 µΜ, (b) 90 µΜ, (c) 
110 µΜ and (d) 77 µΜ. Alamethicin stock solutions were prepared in ethanol and added 
volumes did not exceed 5 µl.
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Figure 8.  A comparison of the effects of alamethicin (a), melittin (b) and FCCP (c) on state 4 
respiration of rat liver mitochondria suspended in a medium containing 50 mM Pi.
Alamethicin concentrations (i) 0·03 µΜ, (ii) 0·045 µΜ, (iii) 0·075 µΜ, (iv) 0·15 µΜ, (ν) 0·3 µΜ. 
Melittin (i) 0·30 µΜ (ii) 0·5 µΜ, (iii) 0·75 µΜ (iv) 1·5 µΜ (ν) 2·25 µΜ. FCCP (i) 0·003 µΜ, 
(ii)0·01 µΜ (iii) 0·0145 µΜ (iv) 0·018 µΜ (ν) 0·039 µΜ (vi) 0·051 µΜ (vii) 0·45 µΜ. Mito- 
chondrial protein concentrations (a) 0·49 mg/ml, (b) 0·59 mg/ml and (c) 0·64 mg/ml for i-v and 
0·75 mg/ml for vi and vii. ADP concentrations (a) 110 µΜ (b) 110 µΜ and (c) 124 µΜ. All other 
conditions as described in figure 7.
 
 
Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2) and the classical protonophoric 
uncoupler, carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), at a Pi 
concentration of 50 mM. Melittin is known to form channels in artificial lipid 
membranes and is therefore expected to uncouple mitochondria (Tosteson and 
Tosteson, 1981). Alamethicin at a concentration of 0·15 µΜ shows a distinct reduction 
in O2 consumption rate after an initial stimulation. In contrast, both melittin and 
FCCP do not show any evidence for a reduction in respiratory rate at the concentration 
studied. 
A constant rate of O2 consumption following peptide addition to state 4 
mitochondria results in a linear fall in O2 level with time, until the anaerobic limit is 
attained. This kind of behaviour is normally observed for classical uncouplers and is 
seen in figure 8 for melittin and FCCP. Changes in O2 consumption rate as a function 
of time, after uncoupler addition result in non-linear, curved traces. It is useful to 
analyze this time dependence of O2 consumption rate. The results of such an analysis 
are shown in figure 9, for various alamethicin concentrations at Pi concentrations of 2·5 
and 50 mM. Respiration rates have been measured by taking slopes at different time 
intervals along the O2 consumption curve. Values have been taken only at points which 
correspond to total O2 concentrations of at least 200 nanogram atoms/ml. At these 
levels there is no inherent dependence of respiration rate on total O2 concentration. In 
the case of Pi = 2·5 mM, there is a time dependent increase in O2 consumption after 
peptide addition, at low alamethicin concentrations. For 0·18 µΜ peptide there is an 
initial increase in respiration rate after addition, followed by a decreased rate of O2 
consumption which appears at shorter times after peptide addition and also at higher 
alamethicin concentrations. Figure 9b demonstrates a marked difference in the 
observed behaviour at Pi = 50 mM. For alamethicin concentrations below 0·75 µΜ the 
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Figure 9. Time dependence of O2 consumption rate following alamethicin addition to 
state 4 mitochondria, (a) Assay medium containing 2·5 mMKH2 PO4 . Alamethicin concentra- 
tions (●), 0·075 µΜ; (О), 0·105 µΜ; (□), 0·18 µΜ; (▲), 0·225 µΜ; (■), 0·49 µΜ; (∆), 1·05 µΜ.
Mitochondrial protein 0·47 mg/ml. (—) indicates normal state 4 respiration rate, (b) Assay 
medium containing 50 mM ΚΗ2 ΡΟ4. Alamethicin concentrations (∆), 0·03 µΜ; (?),
0·045 µΜ;(□),0·06 µΜ;(О), 0·075 µΜ;(▼),0· 15 µΜ;(▲), 0·225 µΜ;(●),0·30 µΜ; (■),0·45 µΜ;
(?), 0·75 µΜ. Mitochondrial protein 0·49 mg/ml – – – indicates normal state 4 respiration 
rate. Inset: Dependence of O 2 consumption rate immediately after alamethicin addition (initial 
slope) on peptide concentration. 
 
 
respiration rate shows little time dependence. However, at higher peptide concentra- 
tions there is a sharp initial enhancement of respiration following peptide addition, 
with a rapid subsequent drop in the rate. At an alamethicin level > 0·3 µΜ a drop below 
the normal state 4 respiration rate is observed, suggestive of an inhibitory effect. 
Figure 9b (inset) shows the influence of alamethicin concentration on the initial O2 
consumption rate, measured immediately after peptide addition. The initial rate 
increases with alamethicin concentration upto 0·3 µΜ, while at higher concentrations a 
decrease sets in.
Phosphate ion concentrations in the medium thus appear to modulate the effects of 
alamethicin on mitochondrial oxidative phosphorylation. At low Pt levels the 
uncoupling effect presumably arises due to formation of transmembrane channels, 
which can dissipate the proton electrochemical gradient across the inner mitochondrial 
membrane. At high Pi concentrations > 10 mM, mitochondria begin to swell (Hunter 
and Ford, 1955), with a steady increase in the swelling rate and extent of swelling upto 
100 mM (unpublished). Even though lower RCI values are obtained at 100 mM Pi 
(~ 4·4) as compared to 2·5 mM Pi (~ 6·7), a significant degree of coupling is still 
obtained at high Pi levels. Since mitochondrial swelling follows changes in membrane 
 
~
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permeabilities, it is reasonable to expect that swelling may also be accompanied by 
changes in the mobilities and accessibilities of membrane bound components of the 
electron transport chain. We speculate that the inhibitory action of the peptide, at high 
Pi concentrations, may be due to direct binding to protein components of the electron 
transport system. Helix macrodipole interactions have been involved to rationalise 
formation of alamethicin aggregates in lipid bilayers (Mathew and Balaram, 1983b). It 
is conceivable that such helix dipole-dipole interactions may mediate the binding of 
helical peptides like alamethicin to transmembrane, helical segments of mitochondrial 
membrane proteins. Since uncouplers like FCCP did not reverse the inhibitory effect of 
alamethicin, the peptide does not appear to act by inhibiting ATP synthetase activity. It 
is pertinent to note that the related polypeptides, efrapeptin (Cross and Kohlbrenner, 
1978) and elvapeptin (Bullogh et al., 1982) have been shown to inhibit soluble F1- 
ATPase. 
A working hypothesis to rationalize the effects of alamethicin on mitochondria is 
presented below, which may serve to stimulate the design of further experiments in this 
area. The initial increase in respiration rate on peptide addition (figure 9) could result 
from incorporation of alamethicin into the lipid phase followed by channel opening. 
The subsequent drop in O2 consumption presumably arises due to inhibition of a 
fraction of respiratory chains, by direct interaction of peptide. The probability of such 
inhibitory interactions increases with alamethicin concentration, as evidenced by a shift 
of the peak in the O2 consumption rate to shorter times after addition of peptide. At 
high Pi concentrations (> 50 mM) peptide incorporation is very rapid and no peak in
respiration rate is observed. The time lag observed for the onset of inhibitory effects is 
probably determined by the diffusibility of alamethicin molecules in the membrane 
plane, which is necessary to reach the site of interaction from the site of insertion of the 
peptide. 
Alamethicin and related natural polypeptides provide structurally well defined 
systems for investigating peptide lipid interactions. Further studies of alamethicin 
effects on mitochondria may clarify the molecular mechanism underlying the 
uncoupling and inhibitory effects manifested by this peptide.
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